Newsroom

Agilent Expands Cell Analysis Portfolio with Acquisition of Luxcel Biosciences

Broadens cell analysis portfolio with addition of complementary plate reader-based cellular assays. Accelerates expansion into pharma/biopharma discovery and in vitro toxicology screening applications. Read more

Twitter

More Twitter